Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: SAPIEN 3 Ultra System PMCF

View source ↗

Summary

This clinical trial update describes the post-market clinical follow-up (PMCF) for Edwards Lifesciences' SAPIEN 3 Ultra System in patients with aortic valve ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAPIEN 3 Ultra System

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Stenosis | Status: ACTIVE_NOT_RECRUITING